Ratings RadNet, Inc.

Equities

RDNT

US7504911022

Market Closed - Nasdaq 16:00:00 2024-05-01 EDT 5-day change 1st Jan Change
50.45 USD +4.02% Intraday chart for RadNet, Inc. +3.66% +45.10%

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • Low profitability weakens the company.
  • With an expected P/E ratio at 93.27 and 63.82 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
+45.10% 3.58B
C+
-17.86% 8.35B
B+
-8.06% 2.47B -
-38.71% 2.46B
B-
-7.96% 2.36B
B-
-13.72% 1.78B
C-
-19.73% 1.53B
A-
-40.78% 1.21B
C+
+8.32% 1.12B
B+
-10.43% 1.09B - -
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes